Loading organizations...
§ Private Profile · Planegg, Bayern, Germany
Biotechnology company develops bio-based binding agents for sustainable material stabilization in agriculture, mining, infrastructure.
Bind-X is an industrial biotechnology company that develops bio-based binding agents and biocementation solutions, based in Planegg, Germany. The organization utilizes microbiologically induced calcite precipitation to create sustainable alternatives to synthetic chemicals for dust suppression, weed control, and soil stabilization across the agriculture, mining, and infrastructure sectors. Operating with a team of approximately 40 employees, the company has raised $11.01 million in total equity funding to commercialize its proprietary platform and B2B product lines, including TerraBind and Bind-DC. Bind-X is backed by notable institutional investors and venture capital firms, including HG Ventures, High-Tech Gründerfonds, and EIT Health. The firm recently secured a €10 million Series B financing round to expand its global supply network, optimize its biological manufacturing processes, and scale production across three international locations. Bind-X was founded in 2011 by Martin Spitznagel.
Bind-X has raised $11.0M across 1 funding round.
Bind-X has raised $11.0M in total across 1 funding round.
Bind-X has raised $11.0M across 1 funding round. Most recently, it raised $11.0M Series B in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 9, 2023 | $11M Series B | — | Greeneering Invest, HG Ventures, K&K 1, Saxovent | Announced |
Bind-X has raised $11.0M in total across 1 funding round.
Bind-X's investors include Greeneering Invest, HG Ventures, K&K 1, Saxovent.